Lymphotoxin αβ is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1333-1338

  Gramaglia, Irene ^a   Mauri, Davide N ^a   Miner, Kent T ^a   Ware, Carl F ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 4; LYMPHOTOXIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; HELPER CELL; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CLONE; CHEMISTRY; DOWN REGULATION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PROTEIN CONFORMATION; TH1 CELL; TH2 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOTOXIN-ALPHA; MICE; MICE, TRANSGENIC; PROTEIN CONFORMATION; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033068145     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ware, C. F., T. L. VanArsdale, P. D. Crowe, and J. L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:175.
2. Murphy, M., B. N. Walter, L. Pike-Nobile, N. A. Fanger, P. M. Guyre, J. L. Browning, C. F. Ware, and L. B. Epstein. 1998. Expression of the lymphotoxin-β receptor on stromal dendritic cells in human lymphoid tissue. Cell Death Differ. 5:497.
3. Ryffel, B., and M. J. Mihatsch. 1993. TNF receptor distribution in human tissues. Int. Rev. Exp. Pathol. 34:149.
4. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-α-deficient mice: effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685.
5. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
6. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal centers. Science 271:1289.
7. Pasparakis, M., L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, and G. Kollias. 1997. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94: 6319.
8. Ettinger, R., J. L. Browning, S. A. Michie, E. W. Van Ewijk, and H. O. McDevitt. 1996. Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-1gGI fusion protein. Proc. Natl. Acad. Sci. USA 93:13102.
9. Rennert, P. D., J. L. Browning, R. Mebius, F. Mackay, and P. S. Hochman. 1996. Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999.
10. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6:491.
11. Fu, Y.-X., G. Huang, Y. Wang, and D. D. Chaplin. 1998. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J. Exp. Med. 187:1009.
12. Gonzalez, M., F. Mackay, J. L. Browning, M. H. Kosco-Vilbois, and R. J. Noelle. 1998. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 187:997
13. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493.
14. Mackay, F., P. R. Bourdon, D. A. Griffiths, P. Lawton, M. Zafari, I. D. Sizing, K. Miatkowski, A. Ngam-ek, C. D. Benjamin, C. Hession, C. M. Ambrose, W. Meier, and J. L. Browning. 1997. Cytotoxic activities of recombinant soluble murine lymphotoxin-α and lymphotoxin-αβ complexes. J. Immunol. 159:3299.
15. Browning, J. L., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867.
16. Kratz. A., N. A. Campos, M. S. Hanson, and N. H. Ruddle. 1996. Chronic inflammation caused by lympholoxin is lymphoid neogenesis. J. Exp. Med. 183: 1461.
17. Sacca, R., C. A. Cuff, W. Lesslauer, and N. H. Ruddle. 1998. Differential activities of secreted lymphotoxin-α3 and membrane lymphotoxin-α1β2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling. J. Immunol. 160:485.
18. Estrov, Z., R. Kurzrock, E. Pocsik, S. Pathak, H. M. Kantarjian, T. F. Zipf, D. Harris, M. Talpaz, and B. B. Aggarwal. 1993. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J. Exp. Med. 177:763.
19. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
20. Browning, J. L., I. D. Sizing, P. Lawton, P. R. Bourdon, P. D. Rennert, G. R. Majeau, C. M. Ambrose, C. Hession, K. Miatkowski, D. A. Griffiths, A. Ngam-ek, W. Meier, C. D. Benjamin, and P. S. Hochman. 1997. Characterization of lymphotoxin-αβ complexes on the surface of mouse lymphocytes. J. Immunol. 159:3288.
21. Millet, I., and N. H. Ruddle. 1994. Differential regulation of lymphotoxin (LT), lymphotoxin-β (LT-β), and TNF-α in murine T cell clones activated through the TCR. J. Immunol. 152:4336.
22. Ware, C. F., P. D. Crowe, M. H. Grayson, M. J. Androlewicz, and J. L. Browning. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T. B. and natural killer cells. J. Immunol. 149:3881.
23. + T cells in vitro: characteristics and antigen-presenting cell requirements. J. Exp. Med. 176:1431.
24. Croft, M., L. Carter, S. L. Swain, and R. W. Dutton. 1994 Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715.
25. + T cells: ICAM-1 or B7-1 can costimulale naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155:45.
26. Crowe, P. D., T. L. VanArsdale, B. N. Walter, K. M. Dahms, and C. F. Ware. 1994. Production of lymphotoxin (LT α) and a soluble dimeric form of its receptor using the baculovirus expression system. J. Immunol. Methods 168:79.
27. Jaiswal, A. I., C. Dubey, S. L. Swain, and M. Croft. 1996. Regulation of CD40-ligand expression on naive CD4 T cells: a role for T cell receptor but not costimulatory signals. Int. Immunol. 8:275.
28. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
29. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
30. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, P. G. Spear, and C. F. Ware. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 8:21.
31. Browning, J. L., I. Dougas, E. A. Ngam, P. R. Bourdon, B. N. Ehrenfels, K. Miatkowski, M. Zafari, A. M. Yampaglia, P. Lawton, W. Meier, C. P. Benjamin, and C. Hession. 1995. Characterization of surface lymphotoxin forms: use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154:33.
32. Croft, M., and S. L. Swain. 1995. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J. Immunol. 154:4269.
33. Broome Powell, M., D. Mitchell, J. Lederman, J. Buckmeier, S. S. Zamvil, M. Graham, N. H. Ruddle, and L. Steinman 1990. Lymphotoxin and tumor necrosis factor-α production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:539.
34. Ruddle, N. H., C. M. Bergman, K., M. McGrath, E. G. Lingenheid, M. L. Grunnet, S. J. Padula, and R. B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
35. Korner, H., F. A. Lemckert, G. Chaudhri, S. Etteldorf, and J. D Sedgwick. 1997. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur. J. Immunol. 27:1973.
36. Suen, W. E., C. M. Bergman, P. Hjelmstrom, and N. H. Ruddle. 1997. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1233.
37. Korner, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585.
38. Riminton, D. S., H. Korner, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice. J. Exp. Med. 187:1517.
39. Picarella, D. E., A. Kratz, C. B. Li, N. H. Ruddle, and R. A. Flavell. 1992. Insulitis in transgenic mice expressing tumor necrosis factor β (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 89:10036.
40. Hochman, P. S., G. R. Majeau, F. Mackay, and J. L. Browning, 1995. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J. Inflamm. 46:220.
41. Pober, J. S., L. A. Lapierre, A. H. Stolpen, T. A. Brock, T. A. Springer, W. Fiers, M. P. Bevilacqua, D. L. Mendrick, and M. A. Gimbrone. 1987. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immunol. 138:3319.
42. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1093.
43. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
44. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
45. + T cells by IL-4 and IFN-γ. J. Immunol. 158:2090.
46. Annunziato, F., R. Manetti, L. Cosmi, G. Galli, C. H. Heusser, S. Romagnani, and E. Maggi. 1997. Opposite role for interleukin-4 and interferon-γ on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur. J. Immunol. 27:2239.